This paper provides a structured overview of acute myocardial infarction (AMI), covering its pathophysiology, aetiology, clinical features, diagnosis, complications, and treatment options. It examines how atherosclerotic plaque rupture triggers thrombus formation and coronary occlusion, leading to irreversible myocardial damage. The paper also applies this knowledge to a patient case study, explaining how uncontrolled risk factors — including hypertension, hyperlipidaemia, and smoking — contribute to AMI onset. Specific clinical manifestations such as chest pain and haemodynamic compromise are explained mechanistically, and the pharmacological rationale for treatments including glyceryl trinitrate, aspirin, and heparin is discussed.
Acute myocardial infarction is a common disease with very grave consequences in morbidity, mortality, and cost to society (Boersma et al., 2003). It has become the leading cause of death in the developed world. It has been estimated that approximately 450,000 people die from coronary disease per year in the United States.
Myocardial infarction primarily occurs when the blood supply to the heart is compromised. Just like all cells of the body, myocardial cells require a constant supply of blood and oxygen to keep functioning. Ischemia beyond a set threshold level exhausts the cells and causes them to be damaged. The term myocardial infarction should be used when there is evidence of necrosis of the myocardium in a clinical setting.
There are five different types of MI, defined according to the clinical situation. Type 1 is a spontaneous MI associated with a primary coronary event, such as occlusion by a thrombus due to plaque rupture. Type 2 is associated with ischemia resulting from a mismatch between increased demand and reduced supply. Type 3 is an MI linked to sudden cardiac death. Types 4 and 5 are MIs associated with percutaneous coronary intervention and coronary artery bypass surgery, respectively.
Many risk factors have been identified in the development of atherosclerotic changes that lead to MI. The six principal factors are increased cholesterol levels, hypertension, diabetes mellitus, tobacco use, a family history of atherosclerotic disease, and male gender.
Most myocardial infarctions are initiated by a disruption in the vascular endothelium. Ongoing atherosclerotic processes stimulate the formation of an intracoronary thrombus. The thrombus then lodges inside a coronary artery and ultimately causes occlusion of blood flow. If the blockage of the coronary artery persists for more than twenty minutes, irreversible damage to muscle cells occurs and ultimately cell death results (Kumar & Abbas et al., 2005).
The course of the disease depends on how effectively the offending agent is treated. As noted above, irreversible damage occurs to the heart if ischemia persists for more than twenty minutes. The course therefore varies with the cause of the MI, the area of the heart involved, and the treatment administered to the patient.
The complications of acute myocardial infarction include ventricular arrhythmias, cardiac rupture (Rosamond et al., 1998), acute mitral insufficiency, heart failure, and mural thrombosis (Keeley et al., 1996).
Improvement in prognosis over the last decade has been driven mainly by early treatment with reperfusion and thrombolytic agents (Hayashi et al., 2005).
The principal clinical features of acute myocardial infarction are as follows (Bruyninckx et al., 2008):
Chest pain; pain radiating to the left arm, shoulder, back, or neck; nausea and vomiting; sweating; and shortness of breath.
The diagnosis of MI is made by ECG and laboratory markers such as creatine kinase, Troponin I, Troponin T, and myoglobin. Two different types of MI can be distinguished by ECG: ST-elevation myocardial infarction (STEMI) and non-ST-elevation MI (NSTEMI).
Treatment involves the integration of antithrombotic therapy combined with timely reperfusion. For ST-elevation MI, primary percutaneous coronary intervention or fibrinolysis is used. For non-ST-elevation MI, invasive investigation and revascularization have been identified as effective treatment approaches (White & Chew, 2008).
Acute myocardial infarction can be prevented by keeping all risk factors under control. Anyone with a positive family history should monitor their lipid levels, blood pressure, and blood glucose levels carefully. In addition, a healthy diet and an active lifestyle are important preventive measures (Anderson et al., 2011).
Mr. White has a positive family history of atherosclerotic problems and heart disease. He has been diagnosed with hypertension and high lipid levels, and he has been a long-term smoker. In short, Mr. White has numerous risk factors that were not adequately controlled. Smoking and elevated lipid levels contributed to plaque deposition in his arteries. Moreover, high blood pressure and smoking hardened his vessels and made them prone to damage. These cumulative insults, combined with persistent elevated blood pressure, caused progressive vascular damage over time.
It is important to note that atherosclerotic plaques take a considerable time to develop and are present in the majority of elderly men and women today. However, it is the rupture of the plaque that initiates an acute myocardial infarction. The plaque that forms has a fibromuscular cap and a core rich in lipids. The primary cause of plaque rupture is the action of metalloproteinases and collagenases. These enzymatic actions cause thinning of the fibromuscular cap. Combined with haemodynamic forces acting on the plaque, the enzymatic activity leads to disruption of the endothelium and ultimately rupture of the cap. This disruption activates the coagulation cascade and increases platelet activation, ultimately leading to thrombus formation. If the thrombus is large enough to occlude the coronary circulation, a myocardial infarction results.
The myocardial infarction that results renders the heart muscle weak and incapable of performing its function. The function of the heart muscle is to pump blood throughout the body. When the heart is undergoing a myocardial infarction, it is unable to contract adequately. The shortage of blood and oxygen to its own muscle causes it to pump weakly or not at all. The left anterior descending artery supplies the left ventricle, including the papillary muscles and the mitral valve. One structural consequence could be rupture of the papillary muscle, which would render the mitral valve insufficient. Furthermore, with the heart unable to pump blood properly, insufficient blood reaches the entire body, and heart failure may ensue.
"Mechanistic explanation of chest pain and low blood pressure"
"Rationale for GTN, aspirin, and heparin use"
You’re 61% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.